loading...

COVID-19 Fears Questionnaire for Chronic Medical Conditions (COVID-19 FQCMC)

Wu Y; Benedetti A; Bartlett SJ; Neupane D; Negeri ZF; Krishnan A; He C; Gagarine M; Carboni-Jiménez A; Bhandari PM; Sun Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Thombs BD; Mouthon L

ProQolid

Basic description

  • Published in 2020
Authors

Wu Y; Benedetti A; Bartlett SJ; Neupane D; Negeri ZF; Krishnan A; He C; Gagarine M; Carboni-Jiménez A; Bhandari PM; Sun Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Thombs BD; Mouthon L

Copyright
No information
Objective
To assess fear among people at risk due to pre-existing medical conditions during the COVID-19 pandemic
Therapeutic area
  • Behavior and Behavior Mechanisms
  • Respiratory Tract Diseases
  • Infections
Therapeutic indication
  • Fear
  • COVID-19
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for Canada and the USA
Translations
1 translation(s)
Bibliographic reference(s) of the original questionnaire

Wu Y, Kwakkenbos L, Henry RS, Tao L, Harb S, Bourgeault A, Carrier ME, Levis B, Sun Y, Bhandari PM, Carboni-Jiménez A, Gagarine M, He C, Krishnan A, Negeri ZF, Neupane D, Mouthon L, Bartlett SJ, Benedetti A, Thombs BD; Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Investigators; SPIN COVID-19 Patient Advisory Team. Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study. J Psychosom Res. 2020 Dec;139:110271 (Full text article)

Wu Y, Kwakkenbos L, Henry RS, Carrier ME, Gagarine M, Harb S, Bourgeault A, Tao L, Carboni-Jiménez A, Negeri Z, Patten S, Bartlett SJ, Mouthon L, Varga J, Benedetti A, Thombs BD; SPIN Patient Advisors; SPIN Investigators. Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study. J Psychosom Res. 2021 Jan;140:110314 (Full text article)

Thombs BD, Kwakkenbos L, Carrier ME, Bourgeault A, Tao L, Harb S, Gagarine M, Rice D, Bustamante L, Ellis K, Duchek D, Wu Y, Bhandari PM, Neupane D, Carboni-Jiménez A, Henry RS, Krishnan A, Sun Y, Levis B, He C, Turner KA, Benedetti A, Culos-Reed N, El-Baalbaki G, Hebblethwaite S, Bartlett SJ, Dyas L, Patten S, Varga J; Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 Patient Advisory Team; SPIN Investigators. Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. J Psychosom Res. 2020 Aug;135:110132 (Full text article)

Thombs B.D. Kwakkenbos L. Henry RS. et al., Protocol for the scleroderma patient-centered intervention network (SPIN) COVID-19 cohort and analysis of changes in symptoms of anxiety and depression from Pre-COVID-19 to COVID-19, OSF Preprints. 2020. June 13.

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us